IS NICOTINE REPLACEMENT THERAPY GIVEN DURING GESTATION CONSIDERED SAFE FOR OFFSPRING NEURODEVELOPMENT IN A RAT MODEL?

Notice brève
dc.contributor.authorTabet, Dana
dc.contributor.supervisorKonkle, Anne
dc.date.accessioned2018-05-15T00:10:42Z
dc.date.available2018-05-15T00:10:42Z
dc.date.issued2018
dc.identifier.urihttp://hdl.handle.net/10393/37694
dc.identifier.urihttps://doi.org/10.20381/ruor-21958
dc.language.isoenen_US
dc.titleIS NICOTINE REPLACEMENT THERAPY GIVEN DURING GESTATION CONSIDERED SAFE FOR OFFSPRING NEURODEVELOPMENT IN A RAT MODEL?en_US
dc.typePosteren_US

Fichiers

Trousse originale

Voici les éléments 1 - 1 sur 1
Vignette d'image
Nom:
DanaTabet.pdf
Taille:
909.14 KB
Format:
Adobe Portable Document Format
Description:
UROP Poster
Télécharger

Trousse de licence

Voici les éléments 1 - 1 sur 1
Vignette d'image
Nom:
license.txt
Taille:
4.92 KB
Format:
Item-specific license agreed upon to submission
Description:
Télécharger

Collections

PIRPC, 2017-18 // UROP, 2017-18